89 related articles for article (PubMed ID: 30534883)
1. [Effect of metformin added to chemotherapy on the survival of patients with acute lymphoblastic leukemia].
Ramos Peñafiel C; Olarte Carrillo I; Ceron Maldonado R; Miranda Peralta E; Rozen Fuller E; Kassack Ipiña JJ; Centeno Cruz F; Collazo Jaloma J; Martínez Tovar A
Rev Med Chil; 2018 Jul; 146(7):846-853. PubMed ID: 30534883
[TBL] [Abstract][Full Text] [Related]
2. [Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment].
Ramos-Peñafiel CO; Martínez-Murillo C; Santoyo-Sánchez A; Jiménez-Ponce F; Rozen-Fuller E; Collazo-Jaloma J; Olarte-Carrillo I; Martínez-Tovar A
Rev Med Inst Mex Seguro Soc; 2014; 52(3):270-5. PubMed ID: 24878085
[TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
4. Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene.
Ramos-Peñafiel C; Olarte-Carrillo I; Cerón-Maldonado R; Rozen-Fuller E; Kassack-Ipiña JJ; Meléndez-Mier G; Collazo-Jaloma J; Martínez-Tovar A
J Transl Med; 2018 Sep; 16(1):245. PubMed ID: 30176891
[TBL] [Abstract][Full Text] [Related]
5. Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.
Jaime-Pérez JC; López-Razo ON; García-Arellano G; Pinzón-Uresti MA; Jiménez-Castillo RA; González-Llano O; Gómez-Almaguer D
Arch Med Res; 2016 Nov; 47(8):668-676. PubMed ID: 28476194
[TBL] [Abstract][Full Text] [Related]
6. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia.
Bostrom B; Uppal P; Chu J; Messinger Y; Gandrud L; McEvoy R
J Pediatr Hematol Oncol; 2013 Oct; 35(7):504-8. PubMed ID: 23823111
[TBL] [Abstract][Full Text] [Related]
9. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.
Spierings LE; Lagarde SM; van Oijen MG; Gisbertz SS; Wilmink JW; Hulshof MC; Meijer SL; Anderegg MC; van Berge Henegouwen MI; van Laarhoven HW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S766-71. PubMed ID: 26350367
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
11. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
12. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
[TBL] [Abstract][Full Text] [Related]
13. Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia.
Lee SM; Lee WS; Shin HJ; Lee JJ; Sohn SK; Moon JH; Eom HS; Won JH; Lee KH; Lee JH; Kim DY; Yoon SS; Kim I; Jung CW; Kim SJ; Kim H; Lee JH; Ryoo HM; Lee GW; Kim SH; Mun YC; Kim MK; Joo YD;
Ann Hematol; 2013 Aug; 92(8):1101-10. PubMed ID: 23558905
[TBL] [Abstract][Full Text] [Related]
14. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and prognosis analysis in 188 children with acute lymphoblastic leukemia of China].
Yang MH; Jia WG; Cao LZ; He YL; Liao N; Chen GL; Luo JM; Xu WQ; Yang J
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):498-501. PubMed ID: 19099804
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Tallen G; Ratei R; Mann G; Kaspers G; Niggli F; Karachunsky A; Ebell W; Escherich G; Schrappe M; Klingebiel T; Fengler R; Henze G; von Stackelberg A
J Clin Oncol; 2010 May; 28(14):2339-47. PubMed ID: 20385996
[TBL] [Abstract][Full Text] [Related]
17. Outcome of acute lymphoblastic leukemia treatment using national protocols at the Queen Sirikit National Institute of Child Health.
Kanjanapongkul S
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S1-5. PubMed ID: 25391165
[TBL] [Abstract][Full Text] [Related]
18. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
Hunault M; Truchan-Graczyk M; Caillot D; Harousseau JL; Bologna S; Himberlin C; Guyotat D; Berthou C; Casassus P; Baranger L; Béné MC; Ifrah N; Gyan E;
Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
[TBL] [Abstract][Full Text] [Related]
19. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.
Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P
Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
Pinheiro Junior ED; Pracchia LF; Beitler de Mauriño B; Martinez GA; Dorlhiac-Llacer PE; Medina AB; Velloso ED
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e7-e14. PubMed ID: 25130688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
